
Though more research still needs to be done, potential for liquid biopsies was shown in a study involving 15,000 patients who represented a multitude of cancer types.

Though more research still needs to be done, potential for liquid biopsies was shown in a study involving 15,000 patients who represented a multitude of cancer types.

This study was presented in conjunction with the 2016 annual meeting of the American Society of Clinical Oncology (ASCO), a gathering of over 30,000 oncology professionals in Chicago.

Women who received intraperitoneal chemotherapy after surgery for ovarian cancer had a reduced amount of disease progression when compared with those who received chemotherapy via IV.

Patients with heavily pretreated relapsed/refractory multiple myeloma showed increased progression-free survival and overall survival rates with isatuximab.

In a phase 3 trial, five-year overall survival was nearly doubled when capecitabine was added to gemcitabine for patients with pancreatic cancer.

Recent findings may make way for a less expensive treatment option for patients with metastatic breast cancer.

What are the next steps for immunotherapy in RCC? CURE spoke with Mark Ball to find out.

Patients with early-stage prostate cancer may be able to shorten their radiation time, thanks to the results of a recent study conducted by the Duke Cancer Institute.

Surgery is still the most promising treatment option for many patients with melanoma, says Giorgos C. Karakousis.

Patients with multiple myeloma live longer without their disease progressing if they get a stem cell transplant, compared with patients who received chemotherapy alone.

Checkpoint blockade immunotherapies like Keytruda are increasing the OS rates for patients with advanced melanoma.

Diet and exercise play a big role in health, especially when it comes to cancer, Katrina Claghorn says.

Melanoma cancer survivor is grateful and feels like she discovered that she is allergic to air.

A side effect of chemotherapy is a weakened immune system, which brings on unwanted occurrences.

The role of radiation continues to change for patients with breast cancer, especially for those over the age of 70, for whom radiation might not be the best option.

Immunotherapy is showing promise for treatment of head and neck cancer who progress after chemotherapy, though there is still a long way to go, says Robert Ferris.

Patients' confidence that they can manage problems related to their colorectal cancer can have a great impact on their recovery, according to a recent study.

Summer presents many challenges for breast cancer survivors, especially those who've experienced mastectomies.

Postmenopausal women with locally-advanced or metastatic HR-positive breast cancer benefited from the use of Faslodex (fulvestrant) as a frontline treatment.

The location of colon cancer may have a say in survival, according to a recent analysis.

A recent study showed that for young women who were treated for cancer, the issue of fertility is not adequately addressed.

Ed completes chemotherapy and tests. The following weeks are very rewarding.

According to a recent study, women with the BRCA1 mutation should not delay their pregnancies because their fertility may quickly decline once they enter their 30s.

Why is the development of vitiligo a predictor of good response in patients taking immunotherapy for melanoma, and what can scientists learn from this?

Triple wild-type melanoma may not respond to approved targeted drugs, but immunotherapy can be an excellent option.

Two-time cancer survivor rants a little about her mom's breast cancer recurrence.

Caregiving is a multi-dimensional act.

After working as an executive in companies like Google and eBay, Jeff Huber switched gears to work on developing a blood test to detect cancer—a mission that has a personal connection for Huber.

A poem about anxiety when facing high-risk cancer.

The unknown is not always as obvious as you may think.